Britain’s most senior breast cancer doctors have called on the health secretary to end confusion which is denying thousands of women a life-changing drug that costs 43p a day.
The pills, which are routinely used to treat osteoporosis, could extend the life of up to 27,000 women with late-stage breast cancer and prevent one in ten deaths.
r which health body is responsible for commissioning the drugs means that three quarters of oncologists cannot prescribe them, according to a recent survey.
Now 41 breast cancer experts have urged Jeremy Hunt to make the commissioning of bisphosphonates a national priority to prevent the death of more than a thousand women eligible for the treatment each year.
It is the responsibility of clinical commissioning groups (CCGs)…